Literature DB >> 24948570

Cytokine balance and cytokine-driven natural killer cell dysfunction in systemic juvenile idiopathic arthritis.

Anneleen Avau1, Karen Put1, Carine H Wouters2, Patrick Matthys3.   

Abstract

Systemic juvenile idiopathic arthritis (sJIA) is a severe inflammatory childhood disorder, characterized by a specific pattern of systemic features and a typical cytokine profile. Patients are at risk to develop macrophage activation syndrome (MAS), an acute life-threatening condition defined by excessive proliferation and activation of macrophages and T cells. Defects of unknown cause in the natural killer (NK) cell cytotoxic capacity are presumed to underlie the pathogenesis of MAS and have been detected in sJIA patients. Here, we provide an overview of the cytokine profiles in sJIA and related mouse models. We discuss the influence of cytokines on NK cell function, and hypothesize that NK cell dysfunction in sJIA is caused by altered cytokine profiles.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Cytokine profile; Defective cytotoxicity; Natural killer cells; Systemic inflammatory syndromes; Systemic juvenile idiopathic arthritis

Mesh:

Substances:

Year:  2014        PMID: 24948570     DOI: 10.1016/j.cytogfr.2014.05.005

Source DB:  PubMed          Journal:  Cytokine Growth Factor Rev        ISSN: 1359-6101            Impact factor:   7.638


  14 in total

1.  Interleukin-1 in monocyte activation phenotypes in systemic juvenile idiopathic arthritis: Observations from a clinical trial of rilonacept, an interleukin-1 inhibitor.

Authors:  Yujuan Zhang; Saloni Gupta; Alexandra Ilstad-Minnihan; Sashi Ayyangar; Arielle D Hay; Virginia Pascual; Norman T Ilowite; Claudia Macaubas; Elizabeth D Mellins
Journal:  Clin Immunol       Date:  2018-06-19       Impact factor: 3.969

2.  Visceral leishmaniasis with haemophagocytic lymphohistiocytosis.

Authors:  John Titus George; Mohammad Sadiq; Elanthenral Sigamani; Alice Joan Mathuram
Journal:  BMJ Case Rep       Date:  2019-02-13

3.  Identification of potential peripheral blood diagnostic biomarkers for patients with juvenile idiopathic arthritis by bioinformatics analysis.

Authors:  Zhi-Qiang Tu; Hai-Yan Xue; Wei Chen; Lan-Fang Cao; Wei-Qi Zhang
Journal:  Rheumatol Int       Date:  2016-11-19       Impact factor: 2.631

Review 4.  Cytokine storm and targeted therapy in hemophagocytic lymphohistiocytosis.

Authors:  Han-Qi Zhang; Si-Wei Yang; Yi-Cheng Fu; Ming-Cong Chen; Cheng-Hao Yang; Ming-Hua Yang; Xiao-Dan Liu; Qing-Nan He; Hua Jiang; Ming-Yi Zhao
Journal:  Immunol Res       Date:  2022-07-11       Impact factor: 4.505

Review 5.  New frontiers in the treatment of systemic juvenile idiopathic arthritis.

Authors:  Susan Canny; Elizabeth Mellins
Journal:  F1000Res       Date:  2017-06-22

6.  Natural Killer Cell Degranulation Defect: A Cause for Impaired NK-Cell Cytotoxicity and Hyperinflammation in Fanconi Anemia Patients.

Authors:  Snehal Shabrish; Madhura Kelkar; Niranjan Chavan; Mukesh Desai; Umair Bargir; Maya Gupta; Priti Mehta; Akanksha Chichra; Chandrakala S; Prasad Taur; Vinay Saxena; Babu Rao Vundinti; Manisha Madkaikar
Journal:  Front Immunol       Date:  2019-03-21       Impact factor: 7.561

7.  Gene-expression analysis of adult-onset Still's disease and systemic juvenile idiopathic arthritis is consistent with a continuum of a single disease entity.

Authors:  Nanguneri Nirmala; Arndt Brachat; Eugen Feist; Norbert Blank; Christof Specker; Matthias Witt; Jan Zernicke; Alberto Martini; Guido Junge
Journal:  Pediatr Rheumatol Online J       Date:  2015-11-20       Impact factor: 3.054

8.  Expert consensus on dynamics of laboratory tests for diagnosis of macrophage activation syndrome complicating systemic juvenile idiopathic arthritis.

Authors:  Angelo Ravelli; Francesca Minoia; Sergio Davì; AnnaCarin Horne; Francesca Bovis; Angela Pistorio; Maurizio Aricò; Tadej Avcin; Edward M Behrens; Fabrizio De Benedetti; Alexandra Filipovic; Alexei A Grom; Jan-Inge Henter; Norman T Ilowite; Michael B Jordan; Raju Khubchandani; Toshiyuki Kitoh; Kai Lehmberg; Daniel J Lovell; Paivi Miettunen; Kim E Nichols; Seza Ozen; Jana Pachlopnik Schmid; Athimalaipet V Ramanan; Ricardo Russo; Rayfel Schneider; Gary Sterba; Yosef Uziel; Carol Wallace; Carine Wouters; Nico Wulffraat; Erkan Demirkaya; Hermine I Brunner; Alberto Martini; Nicolino Ruperto; Randy Q Cron
Journal:  RMD Open       Date:  2016-01-19

Review 9.  Therapeutic Potential of Interferon-γ and Its Antagonists in Autoinflammation: Lessons from Murine Models of Systemic Juvenile Idiopathic Arthritis and Macrophage Activation Syndrome.

Authors:  Anneleen Avau; Patrick Matthys
Journal:  Pharmaceuticals (Basel)       Date:  2015-11-25

10.  Plasma interleukin-37 is increased and inhibits the production of inflammatory cytokines in peripheral blood mononuclear cells in systemic juvenile idiopathic arthritis patients.

Authors:  Miao Feng; Min Kang; Feng He; Zonghui Xiao; Zhewei Liu; Hailan Yao; Jianxin Wu
Journal:  J Transl Med       Date:  2018-10-11       Impact factor: 5.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.